Aldo Amaya

Senior Scientist I at Novartis Institutes for BioMedical Research (NIBR) - Cambridge, Massachusetts, US

Clementine Feau

Research Investigator - Labhead

Contact Clementine Feau

Stephanie Loranger

Director, Alliance Management

Contact Stephanie Loranger

Karen Kotkow

Director, Alliance Management, Business Development & Licensing

Contact Karen Kotkow

Carol Moraff

Senior Scientist I, Chemical Technogies

Contact Carol Moraff

Kevin Marks

Head, Oncology Drug Discovery

Contact Kevin Marks

Bhavesh Pant

Senior Scientist I (Oncology Target Discovery)

Contact Bhavesh Pant

View All Aldo Amaya's Colleagues
Aldo Amaya's Contact Details
HQ
617-871-8000
Location
Cambridge, Massachusetts, United States
Company
Novartis Institutes for BioMedical Research (NIBR)
Aldo Amaya's Company Details
Novartis Institutes for BioMedical Research (NIBR) logo, Novartis Institutes for BioMedical Research (NIBR) contact details

Novartis Institutes for BioMedical Research (NIBR)

Cambridge, Massachusetts, US • 3974 Employees
Major Drugs

Our people With more than 6,000 scientists, physicians and business professionals around the world, we have an open, entrepreneurial and innovative culture that encourages collaboration as we work to push the boundaries of science to change the practice of medicine. NIBR focuses on the following disease areas: • Autoimmunity, Transplantation, and Inflammatory Disease • Cardiovascular & Metabolic Diseases • Immuno-oncology • Infectious Diseases • Musculoskeletal Diseases • Neuroscience • Oncology • Ophthalmology • Respiratory Diseases NIBR has built expertise around several key technology competencies. Each competency combines automation and robotics, computational science, biology and irreplaceable drug discovery knowledge. By building expertise around key technologies, it can be more effectively applied across diseases that share similar mechanisms. • Analytical Sciences • Biologics • Biomarker Development • Chemistry • Developmental and Molecular Pathways • Drug Metabolism & Pharmacokinetics • Genomics Institute of the Novartis Research Foundation › Developing advanced technologies, ranging from cellular genomics and proteomics to combinatorial chemistry and structural biology • Imaging • Metabolism and Pharmacokinetics • Preclinical Safety • Proteomic Chemistry • Translational Medicine NIBR has locations in: • Basel, Switzerland • Cambridge, MA • East Hanover, NJ • Emeryville, CA (SF Bay Area) • San Diego, CA • Shanghai, China Thank you for taking an interest in the NIBR LinkedIn page. Please read Novartis' LinkedIn community guidelines: https://bit.ly/3yAl483

Gnf Cardiac Repari Novartis La Jolla Genomics Institute Of The Novartis Research Foundation Novartis Genomics Shifeng Novartis
Details about Novartis Institutes for BioMedical Research (NIBR)
Frequently Asked Questions about Aldo Amaya
Aldo Amaya currently works for Novartis Institutes for BioMedical Research (NIBR).
Aldo Amaya's role at Novartis Institutes for BioMedical Research (NIBR) is Senior Scientist I.
Aldo Amaya's email address is ***@novartis.com. To view Aldo Amaya's full email address, please signup to ConnectPlex.
Aldo Amaya works in the Major Drugs industry.
Aldo Amaya's colleagues at Novartis Institutes for BioMedical Research (NIBR) are Clementine Feau, Eric McNeill, Stephanie Loranger, Karen Kotkow, Carol Moraff, Kevin Marks, Bhavesh Pant and others.
Aldo Amaya's phone number is 617-871-8000
See more information about Aldo Amaya